Solid-State & Compatibility
Solid-state characterization, salt selection, excipient compatibility and stability studies to build robust, scalable formulations.
Precision multiparticulate systems—pellets, granules, sugar spheres, and pre-formulation intermediates— manufactured in our GMP/ISO-driven facility with a strong Quality by Design (QbD) foundation.
QbD-Driven CDMO
Contract research, pre-formulation intermediates, analytical development, and regulatory support across solid, liquid, topical, and peptide formulations.
Pellet Platforms
IR, DR, EC, controlled and chrono-release systems for advanced oral delivery.
Sugar Spheres & PFIs
USP/Ph.Eur-aligned sugar spheres and pre-formulation intermediates engineered for consistency.
Pre-formulation, formulation development, analytical development and validation, and regulatory dossier support.
Stable, scalable intermediates designed to reduce timelines and de-risk scale-up into final dosage forms.
Premium-grade sugar spheres for pelletization, tailored by particle size and performance for global use.
QbD as a foundation
At Globtech Lifesciences we are dedicated to advancing pharmaceutical innovation through high-quality contract research services and specialized pre-formulation intermediates, built on a robust Quality by Design (QbD) framework.
We focus on premium-grade sugar spheres and PFIs that support pellet-based and complex oral drug delivery systems for regulated and semi-regulated markets worldwide.
Solid-state characterization, salt selection, excipient compatibility and stability studies to build robust, scalable formulations.
Transparent, customer-centric collaboration from early feasibility through tech transfer and post-approval lifecycle support.
Evaluate API properties, polymorphism and solid-state behaviour to define the most reliable formulation pathway.
Physical/chemical testing, dissolution, impurity profiling and ICH-aligned stability programs for lifecycle quality control.
Comprehensive CDMO services covering pre-formulation, formulation development, analytical support, and global regulatory strategy for solid, liquid, topical, and advanced oral peptide products.
End-to-end development support from pre-formulation through dossier preparation for global markets.
Intermediates engineered for stability and manufacturability, forming the backbone of robust dosage forms.
USP/Ph.Eur-aligned sugar spheres and advanced release systems for sophisticated oral dosage designs.
Replace these thumbnails with actual product, pellet and lab images.
Globtech Lifesciences develops pre-formulation intermediates, sugar spheres and finished dosage forms engineered for stability, efficacy, and regulatory acceptance.
R&D is the cornerstone of Globtech Lifesciences, covering oral solids, liquids, peptides & complex generics supported by analytical and stability capabilities.
R&D capabilities →Physical & chemical testing, dissolution, impurity profiling & ICH-aligned stability programs ensuring lifecycle control and product consistency.
Dossier compilation, global submissions, lifecycle management and regulatory strategy for US, EU, Canada, MENA, Turkey, Brazil & more.
From early feasibility to commercial tech transfer, our team partners with you to design robust pellet-based systems, PFIs, and finished products aligned to your target markets.